Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP800517.RAGk4Gsj6JR8O21OO8RCvZ4chy8edCHMUzKWLGeFjEBvQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP800517.RAGk4Gsj6JR8O21OO8RCvZ4chy8edCHMUzKWLGeFjEBvQ130_assertion type Assertion NP800517.RAGk4Gsj6JR8O21OO8RCvZ4chy8edCHMUzKWLGeFjEBvQ130_head.
- NP800517.RAGk4Gsj6JR8O21OO8RCvZ4chy8edCHMUzKWLGeFjEBvQ130_assertion description "[On the other hand, the common BSEP polymorphism V444A (c.1331T>C; allele frequency 65%) emerged as an independent predictor of the success rate in patients with chronic hepatitis C treated with pegylated interferon/ribavirin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800517.RAGk4Gsj6JR8O21OO8RCvZ4chy8edCHMUzKWLGeFjEBvQ130_provenance.
- NP800517.RAGk4Gsj6JR8O21OO8RCvZ4chy8edCHMUzKWLGeFjEBvQ130_assertion evidence source_evidence_literature NP800517.RAGk4Gsj6JR8O21OO8RCvZ4chy8edCHMUzKWLGeFjEBvQ130_provenance.
- NP800517.RAGk4Gsj6JR8O21OO8RCvZ4chy8edCHMUzKWLGeFjEBvQ130_assertion SIO_000772 21691112 NP800517.RAGk4Gsj6JR8O21OO8RCvZ4chy8edCHMUzKWLGeFjEBvQ130_provenance.
- NP800517.RAGk4Gsj6JR8O21OO8RCvZ4chy8edCHMUzKWLGeFjEBvQ130_assertion wasDerivedFrom befree-20150227 NP800517.RAGk4Gsj6JR8O21OO8RCvZ4chy8edCHMUzKWLGeFjEBvQ130_provenance.
- NP800517.RAGk4Gsj6JR8O21OO8RCvZ4chy8edCHMUzKWLGeFjEBvQ130_assertion wasGeneratedBy ECO_0000203 NP800517.RAGk4Gsj6JR8O21OO8RCvZ4chy8edCHMUzKWLGeFjEBvQ130_provenance.